Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.

Karl-Ulrich PetryKaatje BollaertsPaolo BonanniMargaret StanleyRosybel DruryElmar JouraSusanne K KjaerChris J L M MeijerDidier RiethmullerBenoit SoubeyrandPierre Van DammeXavier Bosch

Published in: Human vaccines & immunotherapeutics (2018)

Our simulations demonstrate how evidence can be generated to support decision-making by individual healthcare seekers regarding cervical cancer prevention.

Keyphrases

healthcare
decision making
high grade
molecular dynamics
health information
health insurance
cervical cancer screening